首页>
美国卫生研究院文献>Hospital Pharmacy
>Ranolazine-Induced Reversible T-Wave Inversions with Prolonged QTc Interval; Progressive Multifocal Leukoencephalopathy Linked to Fingolimod; Losartan-Induced Sprue-like Enteropathy; Nivolumab-Induced Psoriasiform Skin Eruption; Hepatitis B Reactivation with Hepatitis C Treatment with Simeprevir and Sofosbuvir
【2h】
Ranolazine-Induced Reversible T-Wave Inversions with Prolonged QTc Interval; Progressive Multifocal Leukoencephalopathy Linked to Fingolimod; Losartan-Induced Sprue-like Enteropathy; Nivolumab-Induced Psoriasiform Skin Eruption; Hepatitis B Reactivation with Hepatitis C Treatment with Simeprevir and Sofosbuvir
The purpose of this feature is to heighten awareness of specific adverse drug reactions (ADRs), discuss methods of prevention, and promote reporting of ADRs to the US Food and Drug Administration’s (FDA’s) MED WATCH program (800-FDA-1088). If you have reported an interesting, preventable ADR to MED WATCH, please consider sharing the account with our readers. Write to Dr. Mancano at ISMP, 200 Lakeside Drive, Suite 200, Horsham, PA 19044 (phone: 215-707-4936; e-mail: ). Your report will be published anonymously unless otherwise requested. This feature is provided by the Institute for Safe Medication Practices (ISMP) in cooperation with the FDA’s MED WATCH program and Temple University School of Pharmacy. ISMP is an FDA MED WATCH partner.
展开▼
机译:此功能的目的是提高对特定药物不良反应(ADR)的认识,讨论预防方法,并促进ADR向美国食品和药物管理局(FDA)的MED WATCH计划(800-FDA-1088)报告。如果您向MED WATCH报告了有趣的,可预防的ADR,请考虑与我们的读者共享该帐户。写信给宾夕法尼亚州霍舍姆市200号湖滨大道200号ISMP上的Mancano博士(电话:215-707-4936;电子邮件:)。除非另有要求,否则您的报告将以匿名方式发布。此功能由美国安全药物规范研究所(ISMP)与FDA的MED WATCH计划和天普大学药学院合作提供。 ISMP是FDA MED WATCH的合作伙伴。
展开▼